|
|
|||
This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major clinical studies, the clinical use of this therapy, and potential adverse effects are reviewed. Relevant formal guidelines, if they exist, are presented. The article ends with the author's clinical recommendations.
A 23-year-old woman with known polycystic ovary syndrome visits her family physician. She has taken oral contraceptive pills in the past but did not tolerate them and is not currently receiving any treatment. She has three or four menstrual
The Clinical Problem
Pathophysiology and Effect of Therapy
Clinical Evidence
Clinical Use
Adverse Effects
Areas of Uncertainty
Guidelines
Recommendations
Source Information
From the Departments of Internal Medicine, Obstetrics and Gynecology, and Pharmacology and Toxicology, Virginia Commonwealth University, Richmond.
Address reprint requests to Dr. Nestler at the Division of Endocrinology and Metabolism, Medical College of Virginia, PO Box 980111, Richmond, VA 23298-0111, or at jnestler@mcvh-vcu.edu.
Related Letters:
Metformin in Polycystic Ovary Syndrome
Raskauskas T. A., Fisken R. A., Targher G., Lippi G., Moghetti P., Mascitelli L., Pezzetta F., Goldstein M. R., Nestler J. E.
Extract |
Full Text |
PDF
N Engl J Med 2008;
358:1866-1868, Apr 24, 2008.
Correspondence
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |